Eli Lilly's CEO is ‘disappointed’ that only 1 in 10 Americans are on GLP-1s
Semafor
—
“We look at that as disappointing on the one hand because our job is to get medicines to patients,” Eli Lilly CEO David Ricks said at Semafor World Economy.